N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer

References

• Yue Y, Liu J, He C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev (in eng). 2015 Jul 1;29(13):1343–1355.
   PubMed Web of Science ®Google Scholar
• He L, Li H, Wu A, et al. Functions of N6-methyladenosine and its role in cancer. Mol Cancer (in eng). 2019 Dec 4;18(1):176.
   PubMed Web of Science ®Google Scholar
• Ping XL, Sun B-F, Wang L, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res (in eng). 2014 Feb;24(2):177–189.
   PubMed Web of Science ®Google Scholar
• Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci U S A (in eng). 1974 Oct;71(10):3971–3975.
   PubMed Web of Science ®Google Scholar
• Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol (in eng). 2011 Oct 16;7(12):885–887.
   PubMed Web of Science ®Google Scholar
• Linder B, Grozhik AV, Olarerin-George AO, et al. Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods (in eng). 2015 Aug;12(8):767–772.
   PubMed Web of Science ®Google Scholar
• Warda AS, Kretschmer J, Hackert P, et al. Human METTL16 is a N6-methyladenosine (m6A) methyltransferase that targets pre-mRNAs and various non-coding RNAs. EMBO Rep (in eng). 2017 Nov;18(11):2004–2014.
   PubMed Web of Science ®Google Scholar
• Wen S, Wei Y, Zen C, et al. Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine. Mol Cancer (in eng). 2020 Dec 12;19(1):171.
   PubMed Web of Science ®Google Scholar
• Gilbert WV, Bell TA, Schaening C. Messenger RNA modifications: form, distribution, and function. Science (in eng). 2016 Jun 17;352(6292):1408–1412.
   PubMed Web of Science ®Google Scholar
• Huang H, Weng H, Chen J. m(6)A Modification in Coding and Non-coding RNAs: roles and Therapeutic Implications in Cancer. Cancer Cell (in eng). 2020 Mar 16;37(3):270–288.
   PubMed Web of Science ®Google Scholar
• Meyer KD, Saletore Y, Zumbo P, et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3ʹ UTRs and near stop codons. Cell (in eng). 2012 Jun 22;149(7):1635–1646.
   PubMed Web of Science ®Google Scholar
• Taft RJ, Pang KC, Mercer TR, et al. Non-coding RNAs: regulators of disease. J Pathol (in eng). 2010 Jan;220(2):126–139.
   PubMed Web of Science ®Google Scholar
• Cech TR, Steitz JA. The noncoding RNA revolution-trashing old rules to forge new ones. Cell (in eng). 2014 Mar 27;157(1):77–94.
   PubMed Web of Science ®Google Scholar
• Peschansky VJ, Wahlestedt C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics (in eng). 2014 Jan;9(1):3–12.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin (in eng). 2020 May;70(3):145–164.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin (in eng). 2020 Jan;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin (in eng). 2018 Nov;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Li J, Liang L, Yang Y, et al. N(6)-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction. Theranostics in eng). 2021;11(6):2581–2593.
   PubMed Web of Science ®Google Scholar
• Li Q, He W, Wan G. Methyladenosine Modification in RNAs: classification and Roles in Gastrointestinal Cancers. Front Oncol in eng). 2020;10:586789.
   PubMedGoogle Scholar
• Fang Z, Hu Y, Hu J, et al. The crucial roles of N(6)-methyladenosine (m(6)A) modification in the carcinogenesis and progression of colorectal cancer. Cell Biosci (in eng). 2021 Apr 9;11(1):72.
   PubMed Web of Science ®Google Scholar
• Yang Y, Hsu PJ, Chen YS, et al. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res (in eng). 2018 Jun;28(6):616–624.
   PubMed Web of Science ®Google Scholar
• Deng X, Su R, Weng H, et al. RNA N(6)-methyladenosine modification in cancers: current status and perspectives. Cell Res (in eng). 2018 May;28(5):507–517.
   PubMed Web of Science ®Google Scholar
• Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell (in eng). 2016 Jul 21;63(2):306–317.
   PubMed Web of Science ®Google Scholar
• Liu J, Yue Y, Han D, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol (in eng). 2014 Feb;10(2):93–95.
   PubMed Web of Science ®Google Scholar
• Weng H, Huang H, Wu H, et al. METTL14 inhibits hematopoietic stem/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification. Cell Stem Cell (in eng). 2018 Feb 1;22(2):191–205.e9.
   PubMed Web of Science ®Google Scholar
• Pendleton KE, Chen B, Liu K, et al. The U6 snRNA m(6)A methyltransferase METTL16 regulates SAM synthetase intron retention. Cell (in eng). 2017 May 18;169(5):824–835.e14.
   PubMed Web of Science ®Google Scholar
• Jia G, Yang C-G, Yang S, et al. Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. FEBS Lett (in eng). 2008 Oct 15;582(23–24):3313–3319.
   PubMed Web of Science ®Google Scholar
• Zheng G, Dahl JA, Niu Y, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell (in eng). 2013 Jan 10;49(1):18–29.
   PubMed Web of Science ®Google Scholar
• Ueda Y, Ooshio I, Fusamae Y, et al. AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells. Sci Rep (in eng). 2017 Feb 13;7(1):42271.
   PubMedGoogle Scholar
• Lin S, Choe J, Du P, et al. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell (in eng). 2016 May 5;62(3):335–345.
   PubMed Web of Science ®Google Scholar
• Li T, Hu PS, Zuo Z, et al. METTL3 facilitates tumor progression via an m(6) A-IGF2BP2-dependentmechanism in colorectal carcinoma. Mol Cancer (in eng). 2019 Jun 24;18(1):112.
   PubMed Web of Science ®Google Scholar
• Chen X, Xu M, Xu X, et al. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer (in eng). 2020 Jun 17;19(1):106.
   PubMed Web of Science ®Google Scholar
• Wang S, Sun C, Li J, et al. Roles of RNA methylation by means of N(6)-methyladenosine (m(6)A) in human cancers. Cancer Lett (in eng). 2017 Nov 1;(408):112–120.
   PubMed Web of Science ®Google Scholar
• Bokar JA, Rath-Shambaugh ME, Ludwiczak R, et al. Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex. J Biol Chem (in eng). 1994 Jul 1;269(26):17697–17704.
   PubMed Web of Science ®Google Scholar
• Wang L, Hui H, Agrawal K, et al. m6A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy. EMBO J (in eng). 2020 Oct 15;39(20):e104514.
   PubMed Web of Science ®Google Scholar
• Uddin MB, Roy KR, Hosain SB, et al. An N(6)-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells. Biochem Pharmacol (in eng). 2019 Feb;160:134–145.
   PubMed Web of Science ®Google Scholar
• Liu T, Li C, Jin L, et al. The prognostic value of m6A RNA methylation regulators in colon adenocarcinoma. Med Sci Monit (in eng). 2019 Dec 11;25:9435–9445.
   PubMed Web of Science ®Google Scholar
• Xiang S, Liang X, Yin S, et al. N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression. Am J Transl Res (in eng). 2020;12(5:1789–1806. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270026/pdf/ajtr0012-1789.pdf
   PubMed Web of Science ®Google Scholar
• Zhou D, Tang W, Xu Y, et al. METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5. Mol Oncol (in eng). 2021 Jan 7;15(8):2172–2184.
   Web of Science ®Google Scholar
• Liu X, Su K, Sun X, et al. Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway. J Exp Clin Cancer Res (in eng). 2021 Apr 15;40(1):132.
   PubMed Web of Science ®Google Scholar
• Shen C, Xuan B, Yan T, et al. m(6) A-dependentglycolysis enhances colorectal cancer progression. Mol Cancer (in eng). 2020 Apr 3;19(1):72.
   PubMed Web of Science ®Google Scholar
• Xu J, Chen Q, Tian K, et al. m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation. Oncol Rep (in eng). 2020 Sep;44(3):973–986.
   PubMed Web of Science ®Google Scholar
• Zhu W, Si Y, Xu J, et al. Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A-dependent manner. J Cell Mol Med (in eng). 2020 Mar;24(6):3521–3533.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kang M, Zhang B, et al. m(6)A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5. Mol Cancer (in eng). 2019 Dec 18;18(1):185.
   PubMed Web of Science ®Google Scholar
• Hou P, Meng S, Li M, et al. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification. J Exp Clin Cancer Res (in eng). 2021 Feb 1;40(1):52.
   PubMed Web of Science ®Google Scholar
• Song P, Feng L, Li J, et al. β-catenin represses miR455-3p to stimulate m6A modification of HSF1 mRNA and promote its translation in colorectal cancer. Mol Cancer (in eng). 2020 Aug 24;19(1):129.
   PubMed Web of Science ®Google Scholar
• Chen H, Gao S, Liu W, et al. RNA N(6)-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m(6) A-GLUT1-mTORC1Axis and is a therapeutic target. Gastroenterology (in eng). 2021 Mar;160(4):1284–1300.e16.
   PubMed Web of Science ®Google Scholar
• Deng R, Cheng Y, Ye S, et al. m(6)A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways. Onco Targets Ther (in eng). 2019;12:4391–4402.
   PubMed Web of Science ®Google Scholar
• Wang S, Gan M, Chen C, et al. Methyl CpG binding protein 2 promotes colorectal cancer metastasis by regulating N6-methyladenosine methylation through methyltransferase-like 14. Cancer Sci (in eng). 2021 Jun 7;112(8):3243–3254.
   Web of Science ®Google Scholar
• Wang S, Fan X, Zhu J, et al. The differentiation of colorectal cancer is closely relevant to m6A modification. Biochem Biophys Res Commun (in eng). 2021 Feb 8;546:65–73.
   PubMed Web of Science ®Google Scholar
• Zhuang J, Lin C, Ye J. m6A RNA methylation regulators contribute to malignant progression in rectal cancer. J Cell Physiol (in eng). 2020 Sep;235(9):6300–6306.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Gao Q, Wang S. Kinase GSK3β functions as a suppressor in colorectal carcinoma through the FTO-mediated MZF1/c-Myc axis. J Cell Mol Med (in eng). 2021 Feb 2. DOI:10.1111/jcmm.16291.
   Web of Science ®Google Scholar
• Yue C, Chen J, Li Z, et al. microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis. J Exp Clin Cancer Res (in eng). 2020 Nov 12;39(1):240.
   PubMed Web of Science ®Google Scholar
• Liu J, Ren D, Du Z, et al. m(6)A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression. Biochem Biophys Res Commun (in eng). 2018 Aug 25;502(4):456–464.
   PubMed Web of Science ®Google Scholar
• Ruan DY, Li T, Wang Y-N, et al. FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis. Oncogene (in eng). 2021 Jul 3;40(33):5168–5181.
   PubMed Web of Science ®Google Scholar
• Li N, Kang Y, Wang L, et al. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci U S A (in eng). 2020 Aug 18;117(33):20159–20170.
   PubMed Web of Science ®Google Scholar
• Ji L, Chen S, Gu L, et al. Exploration of potential roles of m6A regulators in colorectal cancer prognosis. Front Oncol (in eng). 2020;10:768.
   PubMed Web of Science ®Google Scholar
• Bai Y, Yang C, Wu R. YTHDF1 regulates tumorigenicity and cancer stem cell-like activity in human colorectal carcinoma. Front Oncol (in eng). et al. 2019;9:332.
   PubMed Web of Science ®Google Scholar
• Nishizawa Y, Konno M, Asai A, et al. Oncogene c-Myc promotes epitranscriptome m(6)A reader YTHDF1 expression in colorectal cancer. Oncotarget (in eng). 2018 Jan 26;9(7):7476–7486.
   PubMedGoogle Scholar
• Xu D, Shao J, Song H, et al. The YTH domain family of N6-Methyladenosine “readers” in the diagnosis and prognosis of colonic adenocarcinoma. Biomed Res Int (in eng). 2020;2020:9502560.
   PubMed Web of Science ®Google Scholar
• Zhang J, Cheng X, Wang J, et al. Gene signature and prognostic merit of M6a regulators in colorectal cancer. Exp Biol Med (Maywood) (in eng). 2020 Sep;245(15):1344–1354.
   PubMed Web of Science ®Google Scholar
• Tanabe A, Tanikawa K, Tsunetomi M, et al. RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated. Cancer Lett (in eng). 2016 Jun 28;376(1):34–42.
   PubMed Web of Science ®Google Scholar
• Chen RX, Chen X, Xia L-P, et al. N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun (in eng). 2019 Oct 16;10(1):4695.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (in eng). 2004 Jan 23;116(2):281–297.
   PubMed Web of Science ®Google Scholar
• Alarcón CR, Lee H, Goodarzi H, et al. N6-methyladenosine marks primary microRNAs for processing. Nature (in eng). 2015 Mar 26;519(7544):482–485.
   PubMed Web of Science ®Google Scholar
• Ma J-Z, Yang F, Zhou -C-C, et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6-methyladenosine-dependent primary MicroRNA processing. Hepatology. 2017;65(2):529–543.
   PubMed Web of Science ®Google Scholar
• Peng W, Li J, Chen R, et al. Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway. J Exp Clin Cancer Res (in eng). 2019 Sep 6;38(1):393.
   PubMed Web of Science ®Google Scholar
• Chen X, Xu M, Xu X, et al. METTL14 suppresses CRC progression via regulating N6-methyladenosine-dependent primary miR-375 processing. Mol Ther (in eng). 2020 Feb 5;28(2):599–612.
   PubMed Web of Science ®Google Scholar
• Yang L, Ma Y, Han W, et al. Proteinase-activated receptor 2 promotes cancer cell migration through RNA methylation-mediated repression of miR-125b. J Biol Chem (in eng). 2015 Oct 30;290(44):26627–26637.
   PubMed Web of Science ®Google Scholar
• Kapranov P, Cheng J, Dike S, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science (in eng). 2007 Jun 8;316(5830):1484–1488.
   PubMed Web of Science ®Google Scholar
• Zuo L, Su H, Zhang Q, et al. “Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer. Aging (Albany NY) (in eng). 2021 Jan 20;12. DOI:10.18632/aging.202383.
   PubMedGoogle Scholar
• Wu Y, Yang X, Chen Z, et al. m(6) A-inducedlncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1. Mol Cancer (in eng). 2019 Apr 13;18(1):87.
   PubMedGoogle Scholar
• Yang X, Zhang S, He C, et al. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Mol Cancer (in eng). 2020 Feb 28;19(1):46.
   PubMed Web of Science ®Google Scholar
• Lei M, Zheng G, Ning Q, et al. Translation and functional roles of circular RNAs in human cancer. Mol Cancer (in eng). 2020 Feb 15;19(1):30.
   PubMed Web of Science ®Google Scholar
• Zhou C, Molinie B, Daneshvar K, et al. Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs. Cell Rep (in eng). 2017 Aug 29;20(9):2262–2276.
   PubMed Web of Science ®Google Scholar
• Zhang L, Hou C, Chen C, et al. The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs. Mol Cancer (in eng). 2020 Jun 10;19(1):105.
   PubMed Web of Science ®Google Scholar
• Chen C, Yuan W, Zhou Q, et al. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization. Theranostics (in eng). 2021;11(9):4298–4315.
   PubMed Web of Science ®Google Scholar
• Guo Y, Guo Y, Chen C, et al. Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis. Mol Cancer (in eng). 2021 Jun 25;20(1):93.
   PubMed Web of Science ®Google Scholar
• Zhu S, Wang J-Z, Chen D, et al. An oncopeptide regulates m(6)A recognition by the m(6)A reader IGF2BP1 and tumorigenesis. Nat Commun (in eng). 2020 Apr 3;11(1):1685.
   PubMed Web of Science ®Google Scholar
• Shen XP, Ling X, Lu H, et al. Low expression of microRNA-1266 promotes colorectal cancer progression via targeting FTO. Eur Rev Med Pharmacol Sci (in eng). 2018 Dec;22(23):8220–8226.
   PubMed Web of Science ®Google Scholar
• Ni W, Yao S, Zhou Y, et al. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m(6)A reader YTHDF3. Mol Cancer (in eng). 2019 Oct 16;18(1):143.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lu JH, Wu QN, et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Mol Cancer (in eng). 2019 Dec 2;18(1):174.
   PubMed Web of Science ®Google Scholar
• Liu X, Liu L, Dong Z, et al. Expression patterns and prognostic value of m(6) A-relatedgenes in colorectal cancer. Am J Transl Res (in eng). 2019;11(7):3972–3991. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684930/pdf/ajtr0011-3972.pdf
   PubMed Web of Science ®Google Scholar
• Lan H, Liu Y, Liu J, et al. Tumor-associated macrophages promote oxaliplatin resistance via METTL3-mediated m6A of TRAF5 and necroptosis in colorectal cancer. Mol Pharm (in eng). 2021 Feb 8;18(3):1026–1037.
   Google Scholar
• Chen P, Liu XQ, Lin X, et al. Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism. Mol Ther Oncolytics (in eng). 2021 Mar 26;20:228–239.
   PubMed Web of Science ®Google Scholar
• Yi N, Arabella W, Ziyou L, et al. N6-methyladenosine modification: a novel pharmacological target for anti-cancer drug development. Acta Pharm Sin B. 2018;8(6):833–843.
   PubMed Web of Science ®Google Scholar
• Bader JP, Brown NR, Chiang PK, et al. 3-Deazaadenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of Rous sarcoma virus and transformation of chick embryo cells. Virology (in eng). 1978 Sep;89(2):494–505.
   PubMed Web of Science ®Google Scholar
• Chen B, Ye F, Yu L, et al. Development of Cell-Active N6-methyladenosine RNA demethylase FTO Inhibitor. J Am Chem Soc (in eng). 2012 Oct 31;134(43):17963–17971.
   PubMed Web of Science ®Google Scholar
• Huang Y, Yan J, Li Q, et al. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic Acids Res (in eng). 2015 Jan;43(1):373–384.
   PubMed Web of Science ®Google Scholar
• Shusuke T, Timothy JZ, Ajay G. Non-coding RNAs and potential therapeutic targeting in cancer. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188491.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Luo K, Zou Z, et al. Genetic analyses support the contribution of mRNA N(6)-methyladenosine (m(6)A) modification to human disease heritability. Nat Genet (in eng). 2020 Sep;52(9):939–949.
   PubMed Web of Science ®Google Scholar
• Liu T, Yang S, Sui J, et al. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer. J Cell Physiol (in eng). 2020 Jan;235(1):548–562.
   PubMed Web of Science ®Google Scholar
• Wang X, Feng J, Xue Y, et al. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature (in eng). 2016 Jun 23;534(7608):575–578.
   PubMed Web of Science ®Google Scholar
• Carroll PA, Freie BW, Mathsyaraja H, et al. The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis. Front Med (in eng). 2018 Aug;12(4):412–425.
   PubMed Web of Science ®Google Scholar